ARCHIVES

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

This article is from The Cancer Letter archive.

Vol. 06 No. 08 | February 22, 1980

Download PDF Visit The Full Archive

Related Articles

ORI Finds Misconduct By Two Researchers

December 8, 1995

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

July 11, 2014

NCI Preparing RFA for Genetics Network; Patients Want Gene-Environment Studies

August 9, 1996

Protocols Approved During The Month of September 2001

October 26, 2001